The rise of gene-edited embryos has raised a myriad of ethical questions. It involves altering DNA to prevent disease or even to choose specific traits using a method known as CRISPR. In 2018 ...

In December 2017, the US Food & Drug Administration (FDA) approved Luxturna from Spark Therapeutics — the first gene therapy to win market approval in the US. Several other gene therapy programs ...

With the approval of CRISPR-based gene editing therapy in December 2023, researchers are able to use CRISPR to promote and restore unstable haemoglobin levels, an essential protein in delivering ...